THYMUS CARCINOMA

Clinical trials for THYMUS CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new THYMUS CARCINOMA trials appear

Sign up with your email to follow new studies for THYMUS CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Could a new drug help fight a rare thymus cancer?

Disease control Recruiting now

This phase II trial is testing a drug called ivonescimab in 25 people with thymic carcinoma, a rare cancer of the thymus gland that has already been treated. Ivonescimab is an immunotherapy that helps the body's immune system recognize and attack cancer cells. The main goal is to…

Matched conditions: THYMUS CARCINOMA

Phase: PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control

Last updated Jul 09, 2026 00:00 UTC

THYMUS CARCINOMA

Get alerted when new THYMUS CARCINOMA trials appear

Could a new drug help fight a rare thymus cancer?